Focus

Industry

We invest exclusively in new ventures operating within the $3.5 trillion U.S. Healthcare industry. We invest in companies that are both innovative and have the ability to meaningfully contribute to healthcare cost reduction. Example sectors include:

  • Medical technologies
  • Biotechnology
  • Healthcare services
  • Healthcare IT
  • Healthcare enabled AI/ML

Stage

We are early-stage venture investors, often being the first round or institutional round of financing. We generally enter between Seed – Series B, and to date have created many of the companies we have exited or are currently invested in. We will opportunistically invest in later stage deals provided they fit other modalities important to us.

Round

We generally invest between $2-10 million per round, and target $8-20 million in total capital invested over the life of a company, but are flexible based on the needs of the company. We have both worked with a variety of syndicate partners, but are also comfortable leading rounds ourselves. We typically serve on the board of directors of our portfolio companies and strive to maintain our position as lead or co-lead in supporting the firm with its goals.

Geography

Santé maintains offices in Austin and Houston. We invest in companies headquartered in the United States.

News
September 30, 2019 NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
Read More
September 24, 2019 Eric Epstein Joins Santé Ventures
Read More